BiotechTube
Home/AboleIIs Pharma/Ann Meulemans
AM

Ann Meulemans

Chief Executive Officer (CEO)

AboleIIs Pharma

Therapeutic Areas

Autoimmune DiseasesTransplantationInflammatory Diseases

AboleIIs Pharma Pipeline

DrugIndicationPhase
ABO21009Rheumatoid Arthritis (RA)Phase 1

Leadership Team at AboleIIs Pharma

DI
Dr. Ignacio Anegon
Co-founder, Senior Consultant, and Member of the Scientific Advisory Board
DC
Dr. Carole Guillonneau
Co-founder and Head of Research
DF
Dr. François-Xavier Hubert
Co-founder, Past President, and Board Member
View full AboleIIs Pharma profile